Transaction #24764 · Form 4 · 0001205703-26-000032
INCYTE CORP · Exercise / conversion · Common Stock
INCYTE CORP · Transacted October 15, 2026 · Filed October 19, 2026
What does this filing report?
An SEC Form 4 filing for INCYTE CORP records an exercise / conversion involving Common Stock on October 15, 2026. The reported quantity was 455. The filing date is October 19, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- INCYTE CORP
- Company CIK
- 0000879169
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 455
- Reported price
- 61.18
- Reference value
- 27,836.9
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 184,917
- Ownership description
- Not reported
- SEC acceptance time
- Oct 19, 2026, 4:38 PM EDT
- 10b5-1 indication
- Indicated in filing
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- CAGNONI PABLO J ↗
President, Global Head of R&D
CIK 0001205703
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- This includes an aggregate of 183,200 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.
- F2
- Beginning January 17, 2025, options become exercisable in 37 installments, with the first 25% vesting on July 15, 2025 and the remainder vesting monthly over three years.
- F3
- The July 14, 2023 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
- F4
- Beginning January 18, 2024, options become exercisable in 37 installments, with the first 25% vesting on July 14, 2024 and the remainder vesting monthly over three years.
- F5
- The July 15, 2024 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.